Table 2.
Positive Studies | ||||
---|---|---|---|---|
Surgery type | Patients | Most remote follow-up |
Positive findings | Negative findings |
Abdominal hysterectomy99 | 25 | 1 month | Gabapentin reduced incidence of pain 1 month after surgery. |
Did not identify a statistically significant decrease in immediate postoperative pain |
Inguinal herniorrhaphy100 | 30 | 6 months | Gabapentin reduced pain scores at 1, 3, and 6 months after surgery. The number of patients with daily activity adversely affected by pain was lower in the gabapentin group at 1 month. |
The number of patients whose daily activities were adversely affected by pain was similar between groups at 3 months and 6 months |
Abdominal hysterectomy101 | 20 | 6 months | Gabapentin reduced pain scores, pain impact, and incidence of pain at 1, 3, and 6 months. |
Pain impact on activities of daily living was not significantly different at 6 months |
Thyroidectomy102 | 23 | 6 months | Gabapentin reduced total pain score and the incidence of more intense pain at 6 months. |
Nonsignificant trend toward decreased burning sensation and numbness in the gabapentin group. |
Mastectomy16 | 50 | 6 months | At 6 months gabapentin reduced the incidence of burning pain. |
Gabapentin did not reduce global pain severity and opioid use at 6 months. |
Breast cancer surgery17** | 22 | 3 months | Gabapentin and mexiletine each reduced the incidence of burning pain at 3 months. |
Gabapentin did not reduce the incidence of chronic pain, or patients requiring analgesics at 3 months. |
Breast cancer surgery103** | 20 | 6 months | Gabapentin reduced the incidence of chronic pain and analgesic use at 3 months. |
Gabapentin did not reduce the incidence of chronic pain, and analgesic use at 6 months. |
Abdominal hysterectomy104 | 27 | 1 month | Gabapentin reduced the incidence of pain at 1 month. |
Gabapentin did not reduce the incidence of analgesic use at 1 month. |
Negative Studies | ||||
Surgery type | Patients* |
Most remote
follow-up |
Positive findings | Negative findings |
Coronary artery bypass graft surgery18 |
20 | 3 months | Gabapentin reduced pain intensity immediately after surgery |
Gabapentin did not reduce pain intensity at 1 month and 3 months. |
Total hip arthroplasty19 | 28 | 6 months | None | Gabapentin did not reduce pain at any time point (one third of patients lost to remote follow-up). |
Cesarean delivery20 | 16 | 3 months | Gabapentin improved acute but not chronic pain. |
Gabapentin failed to reduce persistent pain, or median pain scores at 3 months. |
Lower limb amputation21 | 15 | 6 months | None | Gabapentin failed to reduce the incidence and intensity of pain at 6 months. |
Indicates the number of gabapentin patients per group available for most remote follow-up.
Modified radical mastectomy or lumpectomy with axillary lymph node dissection.